Anti-obesity Drugs market is estimated to grow at a CAGR of 21.2% by 2034: Visiongain
April 12, 2024 11:17 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Anti-obesity Drugs Market Report 2024-2034: Forecasts by Drug Type (Prescription, OTC), by Mechanism of Action (Glucagon Like Peptide GLP-1 Agonists,...
Anti-Obesity Drugs Market is forecasted to reach USD 8.2 billion by 2032, growing at a 14.6% CAGR from 2023 to 2032
October 02, 2023 11:00 ET
|
Acumen Research and Consulting
LOS ANGELES, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The Anti-Obesity Drugs Market is at the forefront of medical innovation, offering advanced therapeutic solutions for the growing global obesity...
Anti-Obesity Drugs Market Size Expected to Touch US$ 14.8 Billion by 2030 at 23% CAGR | RationalStat Market Report
August 21, 2023 10:30 ET
|
Rationalstat LLC
Wilmington, Delaware, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Global Anti-Obesity Drugs Market is valued at US$ 2.82 billion in 2022 and is expected to grow at a significant CAGR of over 23% over the...
Anti-obesity Drugs Market Size to Surpass USD 22.85 billion by 2030, exhibiting a CAGR of 26.1%
August 16, 2023 07:01 ET
|
Fortune Business Insights
Pune, India, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Fortune Business Insights said the global Anti-obesity Drugs Market size was valued at USD 2.82 billion in 2022. The market is projected to grow from...
With 24.7% CAGR, Anti-Obesity Drugs Market Size worth USD 13.26 Billion in 2029
November 07, 2022 03:08 ET
|
Fortune Business Insights
Pune, India, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The anti-obesity drugs market size valued at USD 1.90 billion in 2021. It is anticipated to grow from USD 2.82 billion in 2022 to USD 13.26 billion by...
Global Anti-Obesity Drugs Market is projected to reach a market value of US$11,079.1 Million by 2031: Visiongain Reports Ltd
August 22, 2022 06:36 ET
|
Visiongain Reports Ltd
Global Anti-Obesity Drugs Market Report, Forecast from 2021 to 2031: - Market Segment by Mechanism of Action (Incretin Mimetics/GLP-1 Agonists, Lipase Inhibitors, SNDRI’s, Serotonin Receptor Agonists,...
Global Anti-Obesity Drugs Market is projected to reach a market value of US$11,079.1 Million by 2031: Visiongain Research Inc
October 25, 2021 07:34 ET
|
Visiongain Ltd
Global Anti-Obesity Drugs Market Report, Forecast from 2021 to 2031: - Market Segment by Mechanism of Action (Incretin Mimetics/GLP-1 Agonists, Lipase Inhibitors, SNDRI’s, Serotonin Receptor Agonists,...
Anti-obesity Drugs Market Size worth USD 3,421.0 Million at 10.1% CAGR; Increasing Research for Developing Therapeutically Effective Drugs to Boost Demand in Europe
February 15, 2021 04:59 ET
|
Fortune Business Insights
Pune, India, Feb. 15, 2021 (GLOBE NEWSWIRE) -- The global anti-obesity drugs market size is set to grow significantly owing to the ever-increasing prevalence of obesity among the global population,...